Shigella Test Kit Market, By Test Type (Lateral flow assays, Enzyme-linked immunosorbent assay (ELISA), Polymerase chain reaction (PCR) assay, and Others), By Technology (Conventional diagnostic tests, Nucleic acid-based tests, and Others), By EndUsers (Hospitals, Diagnostic laboratories, Research institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
Global shigella test kit market size is estimated to be valued at US$ 106.4 Mn in 2023 and is expected to reach US$ 158.9 Mn by 2030, exhibiting a compound annual growth rate (CAGR) of 5.9% during the forecast period of 2023-2030. The market growth is attributed to the increasing prevalence of shigella infections worldwide and the rising demand for accurate and rapid diagnostic tests for the same. However, that market trends and forecasts are subject to change which are based on various factors such as economic, political, and environmental conditions, and needs cautious interpretation.
Global Shigella Test Kit Market Regional Insights
North America is expected to hold 35.3% market share during the forecast period due to the increasing prevalence of shigella infections, due to the availability of advanced healthcare infrastructure and the rising adoption of diagnostic tests for the same in the region.
Europe is expected to hold the 24.5% market share due to the increasing awareness about shigella infections and the rising demand for rapid diagnostic tests in the region.
The Asia Pacific region is expected to witness 7.2% rate during the forecast period due to the increasing incidence of shigella infections, the rising healthcare expenditure, and the growing focus on the development of advanced diagnostic technologies in the region.
Figure 1. Global Shigella Test Kit Market Share (%), By Region, 2023
Analysts’ Views on Global Shigella Test Kit Market:
Shigella is a type of bacteria that causes shigellosis which is a severe form of diarrhea. The test kits are used to detect the presence of this bacteria in stool samples Increase in prevalence of shigella infections and increasing launches in products by the market players is expected to propel the market growth over the forecast period. Moreover, increasing inorganics strategies by the market players will aid in the market growth over the forecast period.
Global Shigella Test Kit Market Drivers:
Increasing incidence of shigella infections: Shigella infections are a significant public health problem globally, which a high incidence in the developing countries. The increasing incidence of shigella infections is driving the demand for accurate and rapid diagnostic tests, thus boosting the growth of the shigella test kit market. For instance, in August, 2022, according to the data published by the National Center for Biotechnology Information (NCBI), the incidence of shigellosis is reported to be 188 Mn cases per year with approximately 1 Mn deaths annually.
Rising demand for accurate and rapid diagnostic tests: The need for accurate and rapid diagnostic tests for shigella infections is increasing due to the significant morbidity and mortality which are associated with the disease. Rising demand for such tests is driving the global shigella test kit market growth.
Increasing healthcare expenditure: The increasing healthcare expenditure globally is driving the adoption of advanced diagnostic tests for shigella infections. This is because, governments and healthcare providers are investing more in the development and adoption of such tests, thus leading to the growth of the Shigella test kit market. For instance, in February 2019, according to the data published by the World Health Organization, there is swift upward trajectory of global health expenditure which is particularly noticeable in low and middle income countries where healthcare expenditures is growing on average 6% annually, as compared with 4% in high income countries.
Growing awareness about shigella infections: The growing awareness about shigella infections among healthcare providers and the general public is driving the demand for accurate and rapid diagnostic tests. This is further boosting the growth of the shigella test kit market.
Global Shigella Test Kit Market Opportunities:
Expansion of the market in developing countries: The high incidence of shigella infections in developing countries presents an opportunity for market players to expand their business in these regions by providing affordable and accessible diagnostic tests. For instance, in 2020, according to the data published by the European Center for Disease Prevention and Contro, 29 countries reported 1930 cases of shigellosis of which 1, 806 were confirmed cases.
Introduction of multiplex test kits: The development of multiplex test kits that can simultaneously detect multiple pathogens, including shigella, presents an opportunity for market players to cater to the growing demand for comprehensive diagnostic tests.
Strategic partnerships and collaborations: Partnerships and collaborations between market players and healthcare providers can help in the development and adoption of advanced diagnostic technologies for shigella infections. Such partnerships can also help in the expansion of the market.
Government initiatives: Government initiatives which are aimed at increasing awareness about Shigella infections and the development and adoption of diagnostic tests presents an opportunity for market players to partner with governments and expand their business.
Shigella Test Kit Market Report Coverage
Report Coverage
Details
Base Year:
2022
Market Size in 2023:
US$ 106.4 Mn
Historical Data for:
2017 to 2021
Forecast Period:
2023 - 2030
Forecast Period 2023 to 2030 CAGR:
5.9%
2030 Value Projection:
US$ 158.9 Mn
Geographies covered:
North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, Central Africa, and North Africa
Segments covered:
By Test Type: Lateral flow assays, Enzyme-linked immunosorbent assay (ELISA), Polymerase chain reaction (PCR) assay, and Others
By Technology: Conventional diagnostic tests, Nucleic acid-based tests, and Others
By End Users: Hospitals, Diagnostic laboratories, Research institutes, and Others
Companies covered:
Thermo Fisher Scientific Inc., Meridian Bioscience Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Creative Diagnostics, Hardy Diagnostics, Luminex Corporation, DiaSorin S.p.A., Sekisui Diagnostics LLC, BioMérieux SA, MP Biomedicals LLC, Coris BioConcept, Alere Inc., Fujirebio Diagnostics Inc., and CTK Biotech Inc.
Growth Drivers:
Increasing prevalence of shigella infections
Rising demand for accurate and rapid diagnostic tests
Increasing healthcare expenditure
Growing awareness about shigella infections
Restraints & Challenges:
Limited availability of advanced healthcare infrastructure
Growing adoption of molecular diagnostic tests: Molecular diagnostic tests, such as PCR-based tests, are increasingly being adopted for the diagnosis of shigella infections due to their high sensitivity and specificity. This trend is likely to continue in the future, thus leading to the growth of the molecular diagnostic segment in the global shigella test kit market.
Increasing use of lateral flow assays: Lateral flow assays are simple, rapid, and cost-effective diagnostic tests that are widely used for the diagnosis of shigella infections. The increasing adoption of lateral flow assays is expected to drive the global Shigella test kit market growth.
Rising focus on point-of-care testing: Point-of-care testing for shigella infections is gaining popularity due to its ability to provide rapid and accurate diagnosis at the point of care. The increasing focus on point-of-care testing is likely to drive the global Shigella test kit market growth.
Growing trend of home testing: Home testing for shigella infections is becoming increasingly popular due to the convenience that it offers. Market players are responding to this trend by developing and marketing home test kits for shigella infections, which are expected to drive the market growth.
Global Shigella Test Kit Market Restraints:
Limited availability of advanced healthcare infrastructure: The limited availability of advanced healthcare infrastructure in developing countries can hinder the global shigella test kit market growth by limiting the adoption of diagnostic tests for shigella infections.
Increase in drug resistance: Increasing shigella drug resistance is expected to hinder the market growth over the forecast period. For instance, in February 2023, according to the data published by the Center for Disease Control and Prevention (CDC), there is an increase in extensively drug resistance shigella infections in the U.S.
Lack of awareness about shigella infections: The lack of awareness about shigella infections among healthcare providers and the general public can hinder the global shigella test kit market growth by limiting the demand for diagnostic tests.
Stringent regulatory requirements: The regulatory requirements for the approval of diagnostic tests can be stringent and time-consuming, which can hinder the global shigella test kit market growth by delaying the introduction of new products.
Counterbalance: More awareness programs about shigella infection among the healthcare providers and the general public needs to be carried out properly. The developing countries should also advance its healthcare infrastructure and also undertake awareness programs for the masses.
Recent Developments
New product launches
In September 2020,Bio-Rad Laboratories, Inc., a life science research company, launched a new ELISA test for the detection of Shigella toxin in stool samples.
In October 2022, Thermo Fisher Scientific, a medical technology company, launched new test for common gastrointestinal bacteria such as Shigella spp
Acquisition and partnerships
In August 2020, Meridian Bioscience, Inc., manufactures, markets, and distributes diagnostic test kits, purified reagents, and related products acquired Exalenz Bioscience Ltd., a company that develops and markets diagnostic tests for gastrointestinal and liver diseases. The acquisition is expected to expand Meridian Bioscience, Inc.'s product portfolio in the gastrointestinal market.
In October 2019, QIAGEN N.V., a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research and McKesson Medical-Surgical Inc. announced a partnership to expand the distribution of QIAGEN's molecular diagnostic tests
In April 2019, Becton, Dickinson and Company (BD), a medical device company and Check-Points B.V. announced a partnership to develop and commercialize molecular diagnostic tests for the detection of antibiotic-resistant bacteria.
Figure 2. Global Shigella Test Kit Market Share (%), By Test Type, 2023
Definition: The shigella test kit market refers to the industry that encompasses the production, distribution, and sales of diagnostic kits which are specifically designed for the detection and identification of Shigella bacteria. These test kits are used to diagnose shigella infections, which are a common cause of bacterial gastroenteritis.
Share
About Author
Nikhilesh Ravindra Patel is a Senior Consultant with over 8 years of consulting experience. He excels in market estimations, market insights, and identifying trends and opportunities. His deep understanding of the market dynamics and ability to pinpoint growth areas make him an invaluable asset in guiding clients toward informed business decisions. He plays a instrumental role in providing market intelligence, business intelligence, and competitive intelligence services through the reports.
The global Shigella Test Kit Market size was valued at USD 106.4 million in 2023 and is expected to reach USD 158.9 million in 2030.
The key factors hampering growth of the global shigella test kit market are limited availability of advanced healthcare infrastructure, lack of awareness about shigella infections, increase in drug resistance, and stringent regulatory requirements.
The major factors driving the global shigella test kit market growth are increasing prevalence of shigella infections, growing awareness about shigella infections, rising demand for accurate and rapid diagnostic tests, and increasing healthcare expenditure.
The leading segment in the Shigella test kit market is the Antibodies/Reagents segment.
The major players operating in the global shigella test kit market are Thermo Fisher Scientific Inc. Meridian Bioscience, Inc., bioMérieux SA, Creative Diagnostics, Sekisui Diagnostics, Luminex Corporation, ZeptoMetrix Corporation, Hardy Diagnostics, Alere Inc., Biomerica, Inc., MP Biomedicals LLC, Coris BioConcept, Alere Inc., Fujirebio Diagnostics Inc., and CTK Biotech Inc.
The North America region is expected to lead the global shigella test kit market.
U.S.: 
U.K. : 
India : 
